Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Wet Age-related Macular Degeneration
Related studies linked through entity extraction aliases.
Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
- Status
- WITHDRAWN
- Phase
- PHASE3
A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics
- Status
- TERMINATED
- Phase
- N/A
Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
- Status
- WITHDRAWN
- Phase
- NA
Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
- Status
- UNKNOWN
- Phase
- PHASE1
Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2